BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34034517)

  • 1. Contemporary and historical selection in Tasmanian devils (
    Stahlke AR; Epstein B; Barbosa S; Margres MJ; Patton AH; Hendricks SA; Veillet A; Fraik AK; Schönfeld B; McCallum HI; Hamede R; Jones ME; Storfer A; Hohenlohe PA
    Proc Biol Sci; 2021 May; 288(1951):20210577. PubMed ID: 34034517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curse of the devil: molecular insights into the emergence of transmissible cancers in the Tasmanian devil (Sarcophilus harrisii).
    Patchett AL; Flies AS; Lyons AB; Woods GM
    Cell Mol Life Sci; 2020 Jul; 77(13):2507-2525. PubMed ID: 31900624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid evolutionary response to a transmissible cancer in Tasmanian devils.
    Epstein B; Jones M; Hamede R; Hendricks S; McCallum H; Murchison EP; Schönfeld B; Wiench C; Hohenlohe P; Storfer A
    Nat Commun; 2016 Aug; 7():12684. PubMed ID: 27575253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intergenomic signatures of coevolution between Tasmanian devils and an infectious cancer.
    Gallinson DG; Kozakiewicz CP; Rautsaw RM; Beer MA; Ruiz-Aravena M; Comte S; Hamilton DG; Kerlin DH; McCallum HI; Hamede R; Jones ME; Storfer A; McMinds R; Margres MJ
    Proc Natl Acad Sci U S A; 2024 Mar; 121(12):e2307780121. PubMed ID: 38466855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of immune responses against devil facial tumour disease in wild Tasmanian devils.
    Pye R; Hamede R; Siddle HV; Caldwell A; Knowles GW; Swift K; Kreiss A; Jones ME; Lyons AB; Woods GM
    Biol Lett; 2016 Oct; 12(10):. PubMed ID: 28120799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmissible cancer influences immune gene expression in an endangered marsupial, the Tasmanian devil (Sarcophilus harrisii).
    Raven N; Klaassen M; Madsen T; Thomas F; Hamede RK; Ujvari B
    Mol Ecol; 2022 Apr; 31(8):2293-2311. PubMed ID: 35202488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Devil Facial Tumor Disease.
    Pye RJ; Woods GM; Kreiss A
    Vet Pathol; 2016 Jul; 53(4):726-36. PubMed ID: 26657222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for induction of humoral and cytotoxic immune responses against devil facial tumor disease cells in Tasmanian devils (Sarcophilus harrisii) immunized with killed cell preparations.
    Kreiss A; Brown GK; Tovar C; Lyons AB; Woods GM
    Vaccine; 2015 Jun; 33(26):3016-25. PubMed ID: 25708088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution in a transmissible cancer: a study of the chromosomal changes in devil facial tumor (DFT) as it spreads through the wild Tasmanian devil population.
    Pearse AM; Swift K; Hodson P; Hua B; McCallum H; Pyecroft S; Taylor R; Eldridge MD; Belov K
    Cancer Genet; 2012 Mar; 205(3):101-12. PubMed ID: 22469509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmissible cancer and longitudinal telomere dynamics in Tasmanian devils (Sarcophilus harrisii).
    Madsen T; Klaassen M; Raven N; Dujon AM; Jennings G; Thomas F; Hamede R; Ujvari B
    Mol Ecol; 2022 Dec; 31(24):6531-6540. PubMed ID: 36205590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conserving adaptive potential: lessons from Tasmanian devils and their transmissible cancer.
    Hohenlohe PA; McCallum HI; Jones ME; Lawrance MF; Hamede RK; Storfer A
    Conserv Genet; 2019 Feb; 20(1):81-87. PubMed ID: 31551664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer- and behavior-related genes are targeted by selection in the Tasmanian devil (Sarcophilus harrisii).
    Hubert JN; Zerjal T; Hospital F
    PLoS One; 2018; 13(8):e0201838. PubMed ID: 30102725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-effect loci affect survival in Tasmanian devils (Sarcophilus harrisii) infected with a transmissible cancer.
    Margres MJ; Jones ME; Epstein B; Kerlin DH; Comte S; Fox S; Fraik AK; Hendricks SA; Huxtable S; Lachish S; Lazenby B; O'Rourke SM; Stahlke AR; Wiench CG; Hamede R; Schönfeld B; McCallum H; Miller MR; Hohenlohe PA; Storfer A
    Mol Ecol; 2018 Nov; 27(21):4189-4199. PubMed ID: 30171778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two of a kind: transmissible Schwann cell cancers in the endangered Tasmanian devil (Sarcophilus harrisii).
    Patchett AL; Coorens THH; Darby J; Wilson R; McKay MJ; Kamath KS; Rubin A; Wakefield M; Mcintosh L; Mangiola S; Pye RJ; Flies AS; Corcoran LM; Lyons AB; Woods GM; Murchison EP; Papenfuss AT; Tovar C
    Cell Mol Life Sci; 2020 May; 77(9):1847-1858. PubMed ID: 31375869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative landscape genetics reveals differential effects of environment on host and pathogen genetic structure in Tasmanian devils (Sarcophilus harrisii) and their transmissible tumour.
    Kozakiewicz CP; Ricci L; Patton AH; Stahlke AR; Hendricks SA; Margres MJ; Ruiz-Aravena M; Hamilton DG; Hamede R; McCallum H; Jones ME; Hohenlohe PA; Storfer A
    Mol Ecol; 2020 Sep; 29(17):3217-3233. PubMed ID: 32682353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservation implications of limited genetic diversity and population structure in Tasmanian devils (
    Hendricks S; Epstein B; Schönfeld B; Wiench C; Hamede R; Jones M; Storfer A; Hohenlohe P
    Conserv Genet; 2017 Aug; 18(4):977-982. PubMed ID: 28966567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmissible cancer in Tasmanian devils: localized lineage replacement and host population response.
    Hamede RK; Pearse AM; Swift K; Barmuta LA; Murchison EP; Jones ME
    Proc Biol Sci; 2015 Sep; 282(1814):. PubMed ID: 26336167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis and molecular biology of a transmissible tumor in the Tasmanian devil.
    Bender HS; Marshall Graves JA; Deakin JE
    Annu Rev Anim Biosci; 2014 Feb; 2():165-87. PubMed ID: 25384139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin and carboplatin trials in Tasmanian devils (Sarcophilus harrisii) with Tasmanian devil facial tumor disease.
    Phalen DN; Frimberger AE; Peck S; Pyecroft S; Harmsen C; Lola S; Moore AS
    Vet J; 2015 Dec; 206(3):312-6. PubMed ID: 26538144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglubolin dynamics and cancer prevalence in Tasmanian devils (Sarcophilus harrisii).
    Ujvari B; Hamede R; Peck S; Pemberton D; Jones M; Belov K; Madsen T
    Sci Rep; 2016 Apr; 6():25093. PubMed ID: 27126067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.